Calyx Pharmaceuticals, established in 1979, operates as a prominent manufacturer of Active Pharmaceutical Ingredients (APIs). Over the years, the company has gained recognition as a key supplier for Anti-TB, Anti-Malarial, and Macrolides APIs. With substantial investment in infrastructure and research and development, Calyx has effectively catered to the demands of both regulated and emerging markets, ensuring that they meet the varied needs of their customers. The production facility is approved by EDQM, WHO – Geneva, and WHO – GMP (India), and has successfully undergone audits by the USFDA for four APIs.

Services include:
– Manufacturing of Active Pharmaceutical Ingredients (APIs)
– Research and Development (R&D)
– Quality Assurance and Compliance
– Custom Manufacturing Services
– Supply Chain Management

Calyx Chemicals remains committed to excellence in the pharmaceutical industry, delivering high-quality products and services to meet stringent regulatory standards. For more information, visit calyxindia.com.